dr melon says the trial is going as he expected. i take this to mean the human patients in the trial are reacting to kevetrin as the strain of cancer in the mice. also that that efficacy was seen far earlier than the 100 to 200 range he expected. (rodman and rental 2013). we were told an avian cancer patient had a lesion disappear at 315.
i myself think this translates into human success and i also think ultimate found where the professionals are acknowledging it with our drug. still waiting for BK on the latter.
also waiting for that publication that should blow the roof off.
News 
Market Data 
Discover 
AI
